Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Fenofibrate for Prevention of DR WorseningDiabetes Complications, cardiovascular disorder, diabetes mellitus, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, retinal disorder, vascular disorderActive, not recruitingPhase 32026-06-29NCT04661358

6 results · Page 1 of 1

66 results · Page 1 of 3

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Austin Research Center for RetinaAustinUnited States13
Austin Retina AssociatesAustinUnited States21
Baylor College of Medicine, Baylor Eye Physicians and SurgeonsHoustonUnited States3
Boston Medical Center CorporationBostonUnited States7
Cascade Medical Research Institute, LLCSpringfieldUnited States5
Dean A. McGee Eye InstituteOklahoma CityUnited States2
Elman Retina Group, P.A.BaltimoreUnited States3
Eye Clinic of WisconsinWausauUnited States12
Florida Retina ConsultantsLakelandUnited States11
Florida Retina Institute, James A. Staman, MD, PA- JacksonvilleJacksonvilleUnited States3
Florida Retina Institute, James A. Staman, MD, PA- OrlandoOrlandoUnited States1
Foundation for Vision Research and Retina Specialists of Michigan, P.C.Grand RapidsUnited States2
Gunderson Health SystemLa CrosseUnited States1
Henry Ford Health SystemDetroitUnited States3
Illinois Retina Associates SC - Oak Park SiteOak ParkUnited States2
John Kenyon American Eye Institute, LLCNew AlbanyUnited States1
Joseph E. Humble and Raymond Haik PTRS DBA Eye Assoc of Northeast LouisianaWest MonroeUnited States3
Joslin Diabetes CenterBostonUnited States37
Kent W. Small, MD, AMCGlendaleUnited States3
Loma Linda UniversityLoma LindaUnited States19
MaculaCareNew YorkUnited States1
Marietta Eye ClinicMariettaUnited States3
Mayo ClinicRochesterUnited States664
Mid-America Retina Consultants, P.A.Overland ParkUnited States3
Midwest Eye InstituteIndianapolisUnited States4